Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy’s Laboratories informs about press release

Date: 05-06-2025

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release ‘Alvotech and Dr. Reddy’s enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) for global markets.’
The above information is a part of company’s filings submitted to BSE.